Obesity, diabetes, and the metabolic syndrome: new challenges in antipsychotic drug therapy.
D014150:Antipsychotic Agents / Q000009:adverse effects* / Q000627:therapeutic use; D001786:Blood Glucose / Q000378:metabolism; D003924:Diabetes Mellitus, Type 2 / Q000139:chemically induced*; D006801:Humans; D024821:Metabolic Syndrome / Q000139:chemically induced*; D009765:Obesity / Q000139:chemically induced*; D012307:Risk Factors; D012559:Schizophrenia / Q000175:diagnosis / Q000188:drug therapy*; D012565:Schizophrenic Psychology
D014150:Antipsychotic Agents; D001786:Blood Glucose